Published online Jan 27, 2020. doi: 10.4240/wjgs.v12.i1.28
Peer-review started: August 3, 2019
First decision: September 10, 2019
Revised: September 24, 2019
Accepted: November 26, 2019
Article in press: November 26, 2019
Published online: January 27, 2020
Processing time: 145 Days and 15.4 Hours
Gastrointestinal neurofibromas are commonly found in patients diagnosed with neurofibromatosis type 1. However, isolated gastrointestinal neurofibromas are a rare entity and only fourteen cases of isolated colorectal neurofibromas have been documented in literature. Isolated gastrointestinal neurofibromas have not been associated with Lynch syndrome (LS). Patients with LS are at an increased risk of colorectal cancer, and are recommended to undergo screening colonoscopy.
A 33-year-old healthy female with a family history of LS was found to have unresectable polyp in the ascending colon on screening colonoscopy suspicious for malignancy. The patient was asymptomatic and had no stigmata of neurofibromatosis. A staging workup for colorectal cancer revealed no evidence of metastatic disease. A discussion with the patient resulted in the decision to undergo a segmental resection with ongoing surveillance. The patient underwent a laparoscopic right hemicolectomy. Histopathology was consistent with a gastrointestinal neurofibroma. Post-operatively, the patient recovered well. She will not require further treatment with regards to her colonic neurofibroma, but will continue to follow-up for ongoing surveillance of her LS.
We present the first case of an isolated colonic neurofibroma in a patient with LS. This case explores considerations for the management of isolated gastrointestinal neurofibromas given the lack of guidelines in literature.
Core tip: Gastrointestinal neurofibromas are rarely found in isolation in the absence of systemic neurofibromatosis. We present herein, the first case of an isolated colonic neurofibroma in a patient with Lynch syndrome. There are currently no guidelines for the management of isolated gastrointestinal neurofibromas due to the lack of studies. We recommend considering establishing a diagnosis with endoscopic mucosal biopsy or ultrasound guided biopsy, reserving resection for patients with symptomatic disease or alternative indications, and continuing to follow patients for the surveillance of neurofibromatosis type 1 to reduce associated morbidity and mortality.